Dongwha Pharm.Co.Ltd (000020) — Capital Reinvestment Ratio
Dongwha Pharm.Co.Ltd (000020) has a Capital Reinvestment Ratio of 0.73x as of December 2025, meaning it reinvests 1% of its operating cash flow (₩9.70 Billion) in capital expenditures (₩7.06 Billion). See how leveraged is Dongwha Pharm.Co.Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dongwha Pharm.Co.Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Dongwha Pharm.Co.Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Dongwha Pharm.Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd from 2011 to 2025. For live market cap and broader valuation context, see Dongwha Pharm.Co.Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.52x | ₩15.70 Billion | ₩55.30 Billion | ▲ +290.0% |
| 2023 | 0.90x | ₩29.17 Billion | ₩26.35 Billion | ▲ +43.2% |
| 2022 | 0.63x | ₩29.22 Billion | ₩18.43 Billion | ▲ +3.6% |
| 2021 | 0.61x | ₩36.03 Billion | ₩21.94 Billion | ▼ -7.1% |
| 2020 | 0.66x | ₩52.23 Billion | ₩34.25 Billion | ▲ +81.6% |
| 2019 | 0.36x | ₩13.28 Billion | ₩4.80 Billion | ▲ +267.6% |
| 2016 | 0.10x | ₩25.48 Billion | ₩2.50 Billion | ▲ +120.0% |
| 2015 | 0.04x | ₩19.83 Billion | ₩885.50 Million | ▼ -52.7% |
| 2014 | 0.09x | ₩13.51 Billion | ₩1.28 Billion | ▼ -76.1% |
| 2013 | 0.40x | ₩8.21 Billion | ₩3.24 Billion | ▲ +53.9% |
| 2012 | 0.26x | ₩25.23 Billion | ₩6.48 Billion | ▲ +29.9% |
| 2011 | 0.20x | ₩46.24 Billion | ₩9.15 Billion | — |